glp-1 gip tirzepatide Tirzepatide, a dual GIP/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction Understand GLP-1/GIP Dual Agonist Tirzepatide

Oxidative stress in obstructive sleep apnea and intermittent hypoxia--revisited--the bad ugly and good: implications to the heart and brain

2020 Expert consensus decision pathway on novel therapies for cardiovascular risk reduction in patients with type 2 diabetes: a report of the American College of Cardiology Solution Set Oversight Committee

Activation of GIP receptors and GLP-1 remains a focus of research due to their involvement in glucose-dependent insulin secretion, modulation of glucagon secretion, regulation of gastric emptying and mechanisms related to the control of satiety and energy intake

It is a derivative of ethylenediamine tetraacetic acid (EDTA)